ALLEA publishes statement on the patentability of inventions involving human embryonic stem cells in Europe

ALLEA, the European Federation of Academies of Sciences and Humanities, warns in a statement published on 19 October 2017 that, in light of recent scientific progress in human embryonic stem cells, parts of the reasoning of a 2014 judgement of the Court of Justice of the European Union (CJEU) “could soon lead to inconsistent and contradictory results” in the field of patentability of inventions involving human embryonic stem cells. Therefore, ALLEA renews its plea for applying the same moral standards that govern research and developments in the area of embryonic stem cells also when it comes to questions of patentability of inventions involving embryonic stem cells.

Read more on the background and to access the statement here

Subscribe to our newsletter